Ganglioneuroblastoma Recruiting Phase 0 Trials for Dotatate (DB14554)

Also known as: Ganglioneuroblastoma (morphologic abnormality) / Ganglioneuroblastoma (disorder)

IndicationStatusPhase
DBCOND0002891 (Ganglioneuroblastoma)Recruiting0
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04040088An Investigational Scan (68Ga-DOTATATE PET/CT) in Diagnosing Pediatric Metastatic Neuroendocrine TumorsDiagnostic